UCSF researcher Maria Shcherbakova highlighted how adaptive deep brain stimulation is improving Parkinson’s care by automatically adjusting brain implants in real time to better control symptoms. The post How Medtronic & UCSF Are Giving Parkinson’s Patients Greater Control Over Their Symptoms appeared first on MedCity News.
Premature claims about Tylenol and autism put politics ahead of science and risk eroding the public trust essential to health. The post Public Health Cannot Survive on Soundbites appeared first on MedCity News.
This requires leveraging technology and partnerships in new ways to break down traditional barriers, designing therapies to fit more seamlessly into patients’ lives, and creating more equitable access to life-sustaining treatments. The post Meeting Patients Where They Are: The Value of Innovation & Collaboration in Expanding Kidney Care Access appeared first on MedCity News.
Over-the-counter continuous glucose monitors have been available for people with and without diabetes for more than a year now — but the data they collect doesn’t seem to be as useful for nondiabetic users, according to new research from Mass General Brigham. The post Over-the-Counter CGMs Are Here — But Do They Really Make Sense…
Health tech companies made several major funding announcements in September. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in September appeared first on MedCity News.
Impact of the government shutdown on health services.Why do patients with sickle cell disease disproportionately leave hospitals against medical advice?New estimates of upcoding.TrumpRx.“FDA will not be able to accept applications for new drugs, generics, biologics, biosimilars or medical devices that require payment of a user fee while the shutdown is in effect”
A clash over the Affordable Care Act that has led to a shutdown of the federal government has ramifications for public health as agencies cease some services. The Trump administration vows mass layoffs during the impasse. The shutdown centered largely on a disagreement over the Obama-era health law. Democrats want a further extension of enhanced…
Rocket Pharmaceuticals voluntarily withdrew its FDA submission for its Fanconi anemia gene therapy. The move follows a corporate restructuring over the summer that refocused the company on its cardiovascular programs. The post Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy appeared first on MedCity News.
AI-generated clinic notes from ambient outpatient visits assist clinicians in numerous ways
Check out news from Oral Genome, DataJoint, Health Wildcatters, and more. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.